Ephraim Katzir Dept. of Biotechnology Engineering, ORT Braude College, Karmiel, Israel.
Nuffield Department of Obstetrics & Gynaecology, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.
Placenta. 2018 Jun;66:17-25. doi: 10.1016/j.placenta.2018.04.013. Epub 2018 Apr 25.
Placental syncytiotrophoblast (STB) release extracellular vesicles (STB-EVs) that communicate physiological and pathological placental signals to the maternal organs. STB-EV release also increases in preeclampsia (PE). Here we explored the cargo of PP13 in STB-EVs from PE versus control placentas.
Placentae were harvested following cesarean section deliveries, and dual placental lobe perfusion was used to harvest STB-EV. Maternal side perfusate was centrifuged at 10,000 × g to yield the STB microvesicles, and then at 150,000 × g to yield STB exosomes. Total STB-EVs (tSTB-EVs) were collected using a one step 150,000 × g centrifugation. Placental origin and size distribution were assessed by Western blotting and Nanoparticle Tracking Analysis, respectively. PP13 expression was determined by Western blot and ELISA.
Placental alkaline phosphatase (PLAP; a STB specific marker) was present in all preparations. Total tSTB-EVs and STB-EXs also expressed the exosome markers such as the Apoptosis-Linked Gene 2-Interacting Protein X (Alix) and the cluster differentiation protein 9 (CD9). PP13 was localized to the outer surface and intra-vesicular compartments of all fractions. Surface to total PP13 ratios were ∼1:1 for all STB-EV preparations. In contrast to the previously reported higher circulating concentrations of soluble PP13 in PE, significantly lower levels of PP13, normalized to total vesicular protein, were observed in PE samples. PP13 reduction in all STB-EVs' sub-populations may be attributed to differences in gestational age (GA). A simple correction for GA suggested that PE may be an important influence.
PP13 is located in and on all types of STB-EVs. Circulating PP13 may therefore be either soluble or associated with extracellular vesicles with different pathophysiological effects in the maternal circulation.
胎盘合体滋养层(STB)释放细胞外囊泡(STB-EVs),将生理和病理胎盘信号传递到母体器官。子痫前期(PE)时 STB-EV 的释放也会增加。在这里,我们探索了 PE 与对照组胎盘 STB-EV 中 PP13 的携带物。
剖宫产分娩后采集胎盘,采用双胎盘叶灌注法采集 STB-EV。将母体侧灌洗液以 10,000×g 离心以获得 STB 微泡,然后以 150,000×g 离心以获得 STB 外泌体。使用一步 150,000×g 离心收集总 STB-EV(tSTB-EV)。通过 Western blot 和纳米颗粒跟踪分析分别评估胎盘来源和大小分布。通过 Western blot 和 ELISA 确定 PP13 的表达。
所有制剂中均存在胎盘碱性磷酸酶(PLAP;STB 特异性标志物)。总 tSTB-EV 和 STB-EX 还表达了外泌体标志物,如凋亡相关基因 2 相互作用蛋白 X(Alix)和簇分化蛋白 9(CD9)。PP13 定位于所有级分的外表面和腔内隔室。所有 STB-EV 制剂的表面与总 PP13 比值约为 1:1。与之前报道的 PE 中可溶性 PP13 循环浓度较高相反,PE 样本中 PP13 的水平明显较低,与总囊泡蛋白相比。所有 STB-EV 亚群中 PP13 的减少可能归因于胎龄(GA)的差异。对 GA 进行简单校正表明,PE 可能是一个重要影响因素。
PP13 位于所有类型的 STB-EV 中。因此,循环 PP13 可能是可溶性的,也可能与母体内具有不同病理生理作用的细胞外囊泡相关。